Insider · CIK 0002038687
Lloyd Minor
Files at BIIB (BIOGEN INC.), CAI (Caris Life Sciences, Inc.). First filing Aug 5, 2026, latest Aug 5, 2026.
In brief
Lloyd Minor files SEC Form 4 as director at BIIB (BIOGEN INC.), and also at CAI (Caris Life Sciences, Inc.). Since Aug 5, 2026, Lloyd Minor has reported 0 open-market buys worth $0 and 1 open-market sell worth $240k, the latest filed on Aug 5, 2026.
A track record needs three past buys with six months of prices behind them; Lloyd Minor has 0, so none is measured yet.
The newest scored trade: sold $240k of BIIB on Aug 3, 2026, filed Aug 5, 2026, scored 18 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $240k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BIIB: BIOGEN INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 18Weak | BIOGEN INC. | $240k 1,186 shares | -31% | +58% from low-7% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 4, 2026 | BIIB BIOGEN INC. | 593 0.00% of outstanding | $119k | Aug 4, 2026 | $121k |
| Aug 3, 2026 | BIIB BIOGEN INC. | 593 0.00% of outstanding | $121k | Aug 3, 2026 | none |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | CAI Caris Life Sciences, Inc. | AGrant or award Common Stock | +13,192 | $0.00 | $0 | 31,813 | Aug 14, 2026 |
| Aug 3, 2026 | BIIB BIOGEN INC. | SOpen-market sale Common Stock10b5-1 | -593 | $203.34 | $121k | 3,282 | Aug 5, 2026 |
| Aug 4, 2026 | BIIB BIOGEN INC. | SOpen-market sale Common Stock10b5-1 | -593 | $200.96 | $119k | 2,689 | Aug 5, 2026 |
| Jun 9, 2026 | BIIB BIOGEN INC. | AGrant or award Common Stock | +1,505 | $0.00 | $0 | 3,875 | Jun 11, 2026 |
| Feb 26, 2026 | CAI Caris Life Sciences, Inc. | AGrant or award Common Stock | +2,492 | $20.06 | $50k | 18,621 | Mar 2, 2026 |
| Jun 17, 2025 | BIIB BIOGEN INC. | AGrant or award Common Stock | +2,370 | $0.00 | $0 | 2,370 | Jun 18, 2025 |
Questions about Lloyd Minor
Answered from the filings on this page, as of the latest one.
Is Lloyd Minor buying or selling?
In the last 12 months Lloyd Minor reported 0 open-market buys worth $0 and 1 open-market sell worth $240k on SEC Form 4; the latest was sold $240k of BIIB on Aug 3, 2026. Grants, option exercises and tax withholding are not counted.
How did Lloyd Minor's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lloyd Minor has 0.
Where does Lloyd Minor file Form 4?
Lloyd Minor has filed Form 4 at BIIB (BIOGEN INC.); CAI (Caris Life Sciences, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.